BofA cuts Qifu Technology stock rating on regulatory headwinds By Investing.com

BofA Securities downgraded Qifu Technology to Neutral from Buy and cut its price target to $13.80 from $42.58, a 68% reduction, citing prolonged regulatory headwinds and no buyback catalyst. The firm also slashed 2026-27 EPS estimates by 57% and 55%, respectively. Recent results were weak as Qifu missed Q4 expectations on EPS of 7.82 versus 9.17 consensus and revenue of 4.09 billion CNY versus 5.03 billion CNY expected.

Analysis

QFIN is shifting from a valuation story to a cash-flow durability debate. When a lender trades at deep-single-digit earnings multiples and still can’t secure a re-rating, the market is signaling that equity value is being subordinated to policy risk and reinvestment uncertainty; that usually keeps the stock cheap for longer than fundamentals alone would imply. The absence of buybacks matters more than it looks: in a low-multiple name, capital returns are often the only credible mechanism to force multiple expansion, so removing that bid can mechanically compress the terminal multiple by another turn or two.

The second-order effect is that QFIN’s weakness likely spills over to other China financials that are perceived as regulatory proxies, even if their operating trends are cleaner. The key distinction is between earnings risk and duration risk: earnings can be managed quarter to quarter, but if the market believes the policy regime caps long-run ROE, then even beats won’t translate into a higher multiple. That makes analyst target cuts less a one-off and more a signal that the buy-side should discount any lender without a visible capital return policy.

Near term, the catalyst set is thin, which means price action is likely to be driven by positioning rather than fundamentals. The stock can still bounce sharply from oversold levels, but without either a regulatory thaw, explicit resumption of repurchases, or a materially better guide on spreads/credit costs, rallies should be sold into. The contrarian case is that the market may be over-penalizing a business with depressed expectations and substantial asset backing; however, in low-P/E financials, cheapness alone is not enough if the path to monetizing that cheapness is blocked.

MS is a mild relative loser only insofar as the downgrade underscores how much the market is demanding cleaner capital allocation from financials broadly. For the broader tape, this is a reminder that ‘value’ in financials can remain a value trap when policy overhangs dominate distribution policy. The best trade is not a blind long on depressed multiples, but a selective long in financials with explicit capital return and less regulatory beta.

Key Decisions for Investors

• Avoid chasing QFIN on valuation alone; if entering long, use only a tactical 3-6 week trade on extreme oversold conditions with a tight stop below the recent low, because the fundamental catalyst stack is weak.
• Pair trade: short QFIN vs. long a higher-quality financial with clearer capital return and lower regulatory beta over the next 1-3 months; the spread should benefit if the market continues to punish policy-sensitive lenders.
• Sell near-dated upside calls on QFIN against a small core long only if liquidity allows; implied rebound risk is real, but absent a catalyst, upside is likely capped by seller supply from trapped longs.
• Do not extrapolate the analyst downgrade into MS fundamentals; treat MS as a sentiment barometer for financials rather than a direct earnings read-through.
• If QFIN announces buybacks or a materially better-than-expected guidance update, reassess immediately: that is the highest-conviction re-rating catalyst and could add 2-3 turns to the multiple over 1-2 quarters.